Super Group (SGHC) Limited Ordinary Shares vs Vir Biotechnology Inc. Common Stock — how do they compare? Super Group (SGHC) Limited Ordinary Shares trades at $11.1 (market cap $5.69B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Super Group (SGHC) Limited Ordinary Shares is far larger — about 3.2× Vir Biotechnology Inc. Common Stock's market cap, and Super Group (SGHC) Limited Ordinary Shares pays a 1.79% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Super Group (SGHC) Limited Ordinary Shares for 6 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SGHC | VIR | |
|---|---|---|
Market Cap | $5.69B | $1.80B |
Volume | 2,162,759 | 1,782,836 |
Sector | Consumer Cyclical | Health |
52-Week High | $15.59 | $11.78 |
52-Week Low | $8.52 | $5.12 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $5.23B | $1.36B |
Dividend Yield | 1.79% | — |
Signals from Pluang's Aura AI — not financial advice
SGHC trades at $11.19, down 0.27% with a bearish technical signal despite strong fundamentals. The company shows robust profitability with 53.31% gross margins and 48.9% ROE, while revenue grew to $2.23B in 2025. Recent earnings missed expectations but analyst consensus remains unanimously bullish with 8 buy ratings. Technical indicators show selling pressure with moving averages signaling bearish momentum.
SGHC presents a compelling value opportunity with attractive valuation multiples (P/E 15.55, EV/EBITDA 8.43) and strong cash flow generation. However, recent earnings misses and bearish technical signals create near-term headwinds. The stock's outlook depends on Q3 earnings delivery and sustained sports betting momentum amid competitive pressures.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.
Read more on SGHC →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →